3B BlackBio DX Stock Screener | Share Price & Fundamental Analysis
3BBLACKBIO
Healthcare Service Provider
Screen 3B BlackBio DX share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹1432.60
▲
22.70 (1.61%)
Market Cap
₹1,214.20 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
4.07
EPS (TTM)
₹55.66
Dividend Yield
0.28%
Debt to Equity
-
52W High
₹2151.50
52W Low
₹1182.30
Operating Margin
35.00%
Profit Margin
29.63%
Revenue (TTM)
₹27.00
EBITDA
₹13.00
Net Income
₹8.00
Total Assets
₹296.00
Total Equity
₹271.00
3B BlackBio DX Share Price History - Stock Screener Chart
Screen 3BBLACKBIO historical share price movements with interactive charts. Analyze price trends and patterns.
3B BlackBio DX Company Profile - Fundamental Screener
Screen 3B BlackBio DX company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for 3BBLACKBIO shares.
Sector
Healthcare Services
Industry
Healthcare Service Provider
Sub-Sector
Healthcare Service Provider
Segment
E
ISIN
INE994E01018
3B BlackBio DX Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen 3BBLACKBIO balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 296 | 248 | 214 | 192 | 194 | 45 | 36 | 30 | 26 | 24 |
| Current Assets | 132 | 123 | 114 | 82 | 118 | 39 | 32 | 26 | 22 | 21 |
| Fixed Assets | 7 | 7 | 8 | 7 | 5 | 4 | 4 | 4 | 3 | 3 |
| Liabilities | ||||||||||
| Total Liabilities | 296 | 248 | 214 | 192 | 194 | 45 | 36 | 30 | 26 | 24 |
| Current Liabilities | 6 | 5 | 4 | 3 | 2 | 2 | 3 | 3 | 4 | 3 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 271 | 226 | 196 | 172 | 148 | 34 | 23 | 19 | 11 | 10 |
| Share Capital | 9 | 9 | 9 | 8 | 8 | 8 | 6 | 6 | 6 | 6 |
| Reserves & Surplus | 260 | 215 | 185 | 146 | 125 | 25 | 16 | 12 | 5 | 4 |
Screen 3BBLACKBIO income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 27 | 27 | 39 | 27 | 23 | 33 | 28 | 19 | 17 | 22 | 20 | 20 | 13 | 19 | 18 |
| Expenses | 15 | 10 | 19 | 13 | 9 | 13 | 10 | 11 | 8 | 11 | 9 | 13 | 7 | 8 | 7 |
| EBITDA | 13 | 16 | 20 | 14 | 15 | 20 | 18 | 9 | 9 | 11 | 12 | 8 | 6 | 11 | 10 |
| Operating Profit % | 35.00% | 53.00% | 43.00% | 43.00% | 56.00% | 56.00% | 59.00% | 41.00% | 45.00% | 41.00% | 50.00% | 32.00% | 44.00% | 53.00% | 50.00% |
| Depreciation | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 13 | 16 | 20 | 14 | 14 | 19 | 18 | 8 | 9 | 10 | 11 | 8 | 6 | 11 | 10 |
| Tax | 5 | 3 | 5 | 5 | 3 | 4 | 4 | 3 | 2 | 3 | 3 | 3 | 2 | 3 | 2 |
| Net Profit | 8 | 13 | 15 | 9 | 11 | 15 | 14 | 5 | 7 | 8 | 9 | 5 | 5 | 8 | 8 |
| EPS | 9.38 | 14.76 | 17.55 | 10.26 | 13.19 | 17.35 | 15.75 | 6.94 | 8.41 | 8.86 | 9.94 | 6.43 | 6.28 | 9.70 | 9.00 |
3B BlackBio DX Cash Flow Screener - Liquidity Fundamentals
Screen 3BBLACKBIO cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 43 | 27 | 20 | 37 | 98 | 7 | 4 | 2 | 1 | 1 |
| Investing Activities | -34 | -20 | 15 | -28 | -70 | -1 | -1 | -1 | 0 | 0 |
| Financing Activities | -3 | -4 | -5 | -15 | -2 | 1 | -1 | 0 | 0 | -1 |
| Net Cash Flow | 7 | 3 | 30 | -6 | 26 | 7 | 2 | 1 | 0 | 0 |
Screen 3BBLACKBIO shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2024-Feb |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 41.28% | 41.28% | 41.28% | 41.29% | 41.29% | 41.29% | 41.29% | 41.29% |
| FII Holding | 2.64% | 2.70% | 2.49% | 2.68% | 3.27% | 3.28% | 2.97% | 2.97% |
| DII Holding | 1.82% | 1.76% | 1.60% | 1.74% | 1.96% | 1.96% | 1.89% | 1.89% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 43.53% | 43.17% | 43.31% | 42.80% | 42.41% | 42.22% | 41.94% | 41.94% |
| Other Holding | 10.73% | 11.09% | 11.32% | 11.49% | 11.07% | 11.26% | 11.92% | 11.92% |
| Shareholder Count | 10,709 | 10,619 | 10,345 | 10,166 | 9,586 | 9,399 | 9,753 | 9,753 |
3B BlackBio DX Dividend Screener - Share Yield Analysis
Screen 3BBLACKBIO dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹4.00 | 0.28% |
| 2024-March | ₹3.00 | 0.19% |
| 2023-March | ₹2.50 | 0.32% |
| 2022-March | ₹10.50 | 2.62% |
| 2021-March | ₹9.00 | 2.64% |
| 2020-March | ₹0.70 | 0.25% |
| 2019-March | ₹0.50 | 0.69% |
| 2018-March | ₹0.50 | 0.66% |
| 2017-March | ₹0.30 | 0.22% |
3B BlackBio DX Index Membership - Market Screener Classification
Screen 3BBLACKBIO by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
3B BlackBio DX Market Events Screener - Corporate Actions
Screen 3BBLACKBIO market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 8.00 /share | 16.71% | ||
| Dividend | ₹ 1.00 /share | 16.71% | ||
| Dividend | ₹ 2.50 /share | 3.50% | ||
| Dividend | ₹ 2.50 /share | 87.10% | ||
| Dividend | ₹ 3.00 /share | 79.92% | ||
| Annual General Meeting | NA | -8.48% | ||
| Dividend | ₹ 4.00 /share | -29.01% | ||
| Annual General Meeting | NA | -4.62% | ||
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | 0.77% |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | 3.22% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | 15.56% |
| 2025-02-13 | 2025-02-13 | Quarterly Result Announcement | NA | -6.07% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | -3.07% |
| 2023-11-16 | 2023-11-16 | Change Of Name | NA | 0.00% |
| 2022-08-05 | 2022-08-05 | Extraordinary General Meeting | NA | 1.50% |
3B BlackBio DX Competitors Screener - Peer Comparison
Screen 3BBLACKBIO competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 25,297 | 46.83 | 2,555 | 11.28% | 492 | 60.03 |
| Vijaya Diagnostic Centre | 10,708 | 70.34 | 700 | 23.06% | 144 | 57.20 |
| Metropolis Healthcare | 9,830 | 61.96 | 1,346 | 10.64% | 146 | 46.81 |
| Thyrocare Technologies | 7,110 | 56.28 | 702 | 20.80% | 91 | 48.33 |
| Nephrocare Health Services | 4,574 | 68.04 | 770 | 33.97% | 67 | |
| Krsnaa Diagnostics | 2,402 | 28.37 | 743 | 16.70% | 78 | 48.50 |
| Suraksha Diagnostic | 1,423 | 45.66 | 256 | 15.11% | 31 | 41.02 |
| One Global Service Provider | 1,263 | 28.65 | 148 | 134.60% | 19 | 59.79 |
| 3B BlackBio DX | 1,214 | 24.67 | 112 | 28.72% | 48 | 57.22 |
| Sastasundar Ventures | 938 | -103.51 | 1,171 | -18.47% | -134 | 38.32 |
3B BlackBio DX Company Announcements - News Screener
Screen 3BBLACKBIO latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-03 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-12-30 | Closure of Trading Window | View |
| 2025-12-28 | Disclosure Under Regulation 29(2) Of SEBI (SAST) Regulations 2011 | View |
| 2025-12-28 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-12-20 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-12-17 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-12-15 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-12-01 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-29 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-11-24 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-20 | Vigilance Awareness Week 2025 | View |
| 2025-11-19 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-13 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-11-13 | Board Meeting Outcome for Outcome Of Board Meeting | View |
| 2025-11-13 | Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended 30Th September2025 | View |
| 2025-11-06 | Board Meeting Intimation for Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended On 30Th September 2025. | View |
| 2025-11-01 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-10-16 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-10-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |